Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria...
One great thing about the HPS conference is the doctors are pretty available to speak to if you really want to ask someone a question. Here. Dr. Santiago, a geneticist from Puerto Rico, makes himself at home on the floor in the hospitality suite because it got so crowded there weren't enough places to sit. He's talking to Carmen and Donna. How often do you get a chance to sit on the floor eating lunch with a doc. while picking his brain?
Comments